Method for treating metastatic prostate cancer

A method of treating metastatic prostate cancer comprising the steps of:

• contact a product to a part of a human affected by metastatic prostate cancer wherein the product comprises a first surfactant or pharmaceutically acceptable salt thereof and a second surfactant to an area affected by metastatic prostate cancer wherein the first surfactant is represented by the following chemical structure:
• wherein R1 comprises an alkyl, cycloalkyl, polycycloalkyl, heterocycloalkyl, aryl, alkaryl, aralkyl, alkoxy, alkanoyl, aroyl, alkenyl, alkynyl and/or cyano group containing approximately 1 to approximately 25 carbon atom(s), wherein the carbon atom(s) may be a linking group to, or part of, a halogen, a N, O, and/or S containing moiety, and/or one or more functional groups comprising alcohols, esters, ammonium salts, phosphonium salts, and combinations thereof;
• a linkage to a dimer;
• a linkage to an oligomer;
• and/or a linkage to a polymer;
• wherein R2 comprises NCS;
• wherein R3-R5 are the same or different and comprise H;
• OH;
• an alkyl, cycloalkyl, polycycloalkyl, heterocycloalkyl, aryl, alkaryl, aralkyl, alkoxy, alkanoyl, aroyl, alkenyl, alkynyl and/or cyano group containing approximately 1 to approximately 25 carbon atom(s), wherein the carbon atom(s) may be a linking group to, or part of, a halogen, a N, O, and/or S containing moiety, and/or one or more functional groups comprising alcohols, esters, ammonium salts, phosphonium salts, and combinations thereof;
• a linkage to a dimer;
• a linkage to an oligomer;
• and/or a linkage to a polymer with the proviso that at least one of R3-R5 comprise an alkyl, cycloalkyl, polycycloalkyl, heterocycloalkyl, aryl, alkaryl, aralkyl, alkoxy, alkanoyl, aroyl, alkenyl, alkynyl and/or cyano group containing approximately 8 to approximately 25 carbon atom(s), wherein X comprises a counter cation such as, but not limited to, alkali metals, alkaline earth metals, transition metals, s-block metals, d-block metals, p-block metals, NZ4+, wherein Z comprises, H, R6, OR6, and wherein R6 comprises an alkyl, cycloalkyl, polycycloalkyl, heterocycloalkyl, aryl, alkaryl, aralkyl, alkoxy, alkanoyl, aroyl, alkenyl, alkynyl and/or cyano group containing approximately 1 to approximately 25 carbon atom(s), wherein the carbon atom(s) may be a linking group to, or part of, a halogen, a N, O, and/or S containing moiety, and/or one or more functional groups comprising alcohols, esters, ammonium salts, phosphonium salts, and combinations thereof;
• a linkage to a dimer;
• a linkage to an oligomer;
• and/or a linkage to a polymer;
• and
• wherein the product further comprises one or more solvents.

A method of treating metastatic prostate cancer comprising the steps of:

• applying a product containing a surfactant or pharmaceutically acceptable salt thereof to an area of a patient affected by metastatic prostate cancer wherein the surfactant is represented by the following chemical structure:
• wherein R1 is selected from the group consisting of an alkyl group containing 1 to 25 carbon atom(s);
• wherein R2 is selected from the group consisting of NCS;
• and wherein R3-R5 are each independently selected from the group consisting of H;
• OH;
• and an alkyl, and alkanoyl group containing 1 to 25 carbon atom(s) with the proviso that at least one of R3-R5 is selected from the group consisting of an alkyl, and alkanoyl, group containing 8 to 25 carbon atoms;
• and wherein X comprises a counter cation;
• and
• wherein the product further comprises one or more solvents.